TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
Back to search
Official data from USPTO
T ACCESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/22/2024
Trademark type
Combined
Nice classes
5, 41, 42, 44
Filing date
12/22/2016
Registration date
11/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
03/22/2024
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Valby, DK
Examiner
SEVERSON, KAREN
Law office
M80
Mark description
The mark consists of a letter "t" and the word "access" in lowercase in orange letters with a blue-green curved arrow between the "t" pointing to the word "access". The white background is transparent and not claimed as a feature of the mark.
Holders and representatives
Holders
H. Lundbeck A/S
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementiaAlzheimer's disease and disorderdizzinessstrokedepressioncognitive impairmentcognitive disorders and diseasesmood disorderspsychosisanxietyapathyepilepsysclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderschizophreniabipolar disorder and diseaseADHDcancerpainalcoholism and chemical dependency; diagnostic agentsreagentspreparations and substances for medical purposes
Class 41
Educational servicesproviding classescoursesseminars in the field of medicine and disease prevention; providing medical training; arranging and conducting seminarseducational conferencessymposiumsworkshops and courses in the field of medicine and disease prevention; educational servicesproviding classesseminarsworkshopstraining in the fields of scientific research and development in the fields of pharmaceuticalssciencepharmaceutical clinical studiestests and trialsmedical diagnosticsmedicinepharmaceuticalsmedical disordersdiseasesdisease treatment and prevention; providing the aforementioned services electronicallyvia cable or Internet or other electronic media; arranging and conducting in-person educational forums in the fields of medicine and pharmaceuticals; on-line training programs in the fields of medicine and pharmaceuticals; providing temporary use of online non-downloadable publications in the nature of booksreportsbrochuresbookletsleafletspatient information leafletsmagazinesjournalsteaching and educational curriculum in the fields of medical and pharmaceutical research and development
Class 42
Scientific and technological servicesresearch and design in the field of medicine; industrial analysis and research services in the field of pharmaceuticals; providing temporary use of online non-downloadable software for accessing an online searchable database in the fields of medical research and developmentscienceclinical tests and trialsmedical diagnosticsmedicinepharmaceuticalsmedical disordersdiseasesdisease treatment and prevention; pharmaceutical research and development; scientific and technological servicesresearch in the fields of medical disordersdiseasesdisease preventioncentral nervous systemneurological disorderscentral nervous system disordersdiseasesrelated pharmaceuticals; medical researchconducting medical trials and tests for others in the field of pharmaceuticals; conducting clinical researchtrialstesting for others in the field of pharmaceuticals; medical diagnostic research and tests and clinical trials for others; providing medical and pharmaceutical information in the field of research and developmentscienceclinical trials and tests
Class 44
Medical services; healthcare services; therapeutic clinical services in the field of brain and central nervous systems diseases and disorders; providing medical and healthcare information; providing information in the field of the therapeutic properties of pharmaceuticals; psychiatry and clinical psychology services in the fields of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disordersdiseases and pharmaceuticals; providing medical information in the field of diagnosticsmedicinepharmaceuticalsmedical disordersdiseasesdisease treatment and prevention; providing online medical data and analyses designed to provide patients and clients with customized medical information regarding medical dosingmedical diagnosestherapeutic counseling servicesnon-surgical medical management of diseases and medical disorders
Publications
History of USPTO decisions and trademark events.
31 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/22/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/23/2024
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
01/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2024
ES8R
TEAS SECTION 8 RECEIVED
11/13/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2017
PUBO
PUBLISHED FOR OPPOSITION
08/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/19/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/19/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/19/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/19/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/05/2017
ALIE
ASSIGNED TO LIE
06/29/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/29/2017
GNRT
NON-FINAL ACTION E-MAILED
03/29/2017
CNRT
NON-FINAL ACTION WRITTEN
03/29/2017
DOCK
ASSIGNED TO EXAMINER
03/23/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2017
NWAP
NEW APPLICATION ENTERED
12/27/2016
Continuous trademark protection
Get notified about every new filing that threatens T ACCESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.